Evidence map›Paper›PMID 41997298›Full record

Observational studyTransplantation and cellular therapy2026

Factors Associated With Pre-donation Health-related Quality-of-Life Among Pediatric Sibling Hematopoietic Cell Donors: A DonorKids QL Study.

Galen E Switzer, Jessica G Bruce, Bronwen E Shaw, Vidya Kuniyil, James W Varni, Brandan J Butler, Connor Erickson, Alisha Mussetter, Allison Neutzling, Hisham Abdel-Azim and 32 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Transplantation and cellular therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Galen E SwitzerDepartments of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania; Clinical and Translational Science, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: gswitzer@pitt.edu.
Jessica G BruceDepartments of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Bronwen E ShawDepartment of Medicine, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, Wisconsin.
Vidya KuniyilDepartments of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
James W VarniColleges of Architecture and Medicine, Texas A&M University, College Station, Texas.
Brandan J ButlerCIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, Minnesota.
Connor EricksonCIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, Minnesota.
Alisha MussetterCIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, Minnesota.
Allison NeutzlingCIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, Minnesota.
Hisham Abdel-AzimHematology/Oncology Division, Loma Linda University Children's Hospital, Loma Linda, California.
Paibel Aguayo-HiraldoChildren's Hospital Los Angeles, University of Southern California, Los Angeles, California.
Eric J AndersonUniversity of California San Diego/Rady Children's Hospital, San Diego, California.
Victor M AquinoUT Southwestern Medical Center Dallas, Dallas, Texas.
Karlie BoonePediatric Hematology/Oncology, University of Colorado, Aurora, Colorado.
Farid BouladDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Joseph H ChewningPediatric Blood and Marrow Transplant Program, University of Alabama at Birmingham, Birmingham, Alabama.
Jessica CooperPediatric Hematology/Oncology, University of Colorado, Aurora, Colorado.
Ann DahlbergClinical Research Division, Fred Hutchinson Cancer Center, Department of Pediatrics, University of Washington, Seattle, Washington State.
Christopher C DvorakDivision of Pediatric Allergy, Immunology & Bone Marrow Transplantation, University of California San Francisco, San Francisco, California.
Jorge Galvez-SilvaBlood and Bone Marrow Transplant Program, Nicklaus Children's Hospital, Miami, Florida.
Ann E HaightAflac Cancer and Blood Center, Emory University School of Medicine, Atlanta, Georgia.
Jennifer A HoagDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
Michelle HudspethPediatric Hematology/Oncology, Medical University of South Carolina, Charleston, South Carolina.
David JacobsohnDivision of Blood and Marrow Transplantation, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC.
Kimberly A KasowDivision of Pediatric Hematology/Oncology at the University of North Carolina, Chapel Hill, North Carolina.
Carrie L KitkoDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Lakshmanan KrishnamurtiDivision of Pediatric Hematology oncology and Bone Marrow Transplant, Department of Pediatrics, Yale University, New Haven, Connecticut.
Lisa MaddenDivision of Pediatric Hematology Oncology, University of California, Davis, Sacramento, California.
Holly K MillerDepartment of Medicine, Mayo Clinic Arizona, Phoenix Children's Hospital, Phoenix, Arizona.
Erin MoralesDivision of Pediatric Hematology and Oncology, Intermountain Primary Children's Hospital, Huntsman Cancer Institute, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah.
Timothy S OlsonCell Therapy and Transplant Section, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Anna B PawlowskaDepartment of Pediatrics, City of Hope, Duarte, California.
Vinod K PrasadPediatric Transplant & Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.
Troy C QuiggPediatric Blood and Marrow Transplantation, Helen DeVos Children's Hospital, Grand Rapids, Michigan.
Andromachi ScaradavouDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Niketa C ShahDivision of Pediatric Hematology oncology and Bone Marrow Transplant, Department of Pediatrics, Yale University, New Haven, Connecticut.
Shalini ShenoyDivision of Pediatric Hematology Oncology, Washington University School of Medicine, St. Louis, Missouri.
Nancy B TerwilligerDivision of Pediatric Hematology, Oncology, and Blood and Marrow Transplant, Children's Mercy Hospital and Clinics, Kansas City, Missouri.
Lori WienerCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Gregory A YanikPediatric Hematology-Oncology, University of Michigan, Ann Arbor, Michigan.
Lolie C YuLSUHSC/Children's Hospital New Orleans, Division of Hematology-Oncology/HSCT Program, New Orleans, Louisiana.
Michael A PulsipherDivision of Pediatric Hematology and Oncology, Intermountain Primary Children's Hospital, Huntsman Cancer Institute, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah.

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
Identifying Predictors of Poor Health-Related Quality-of-life among Pediatric Hematopoietic Stem Cell DonorsR01HL131731 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PULSIPHER, MICHAEL A, SWITZER, GALEN E. · 2018 to 2022
$3.6M
NCI NIH HHS U24 CA076518NHLBI NIH HHS R01 HL131731
6 · The paper itself

Abstract

Due to limited published data assessing pediatric hematopoietic cell donor experiences, we previously conducted one of the largest quantitative investigations of pediatric donor experiences and health-related quality-of-life (HRQoL) at the time (RDSafe). Findings from RDSafe demonstrated that a subset of pediatric HC donors experienced very poor HRQoL; unfortunately, that dataset addressed only a limited number of factors, and key associations explaining this poor HRQoL were not found. In this study, our goal was to address that deficit by describing pre-donation donor HRQoL in detail and identifying factors across five key domains that were associated with donor HRQoL. We conducted a prospective study involving 29 centers in the US (31 enrolled, 29 contributed data). After consent at the local center, data were collected via telephone interviews with donors, recipients, other siblings, and parents, and via a web-based survey from transplant centers. Family data (donors, recipients, sibling, parents) were collected before donation and at four weeks, six months, and one-year post-donation. Domains assessed included sociodemographics, general and donation-related psychosocial, clinical, and transplant center characteristics. Data presented here are from the 133 donor-parent pairs who completed the pre-donation interview, 64 recipients, 59 non-donor/non-recipient siblings in these related donor families, and 78 comparison siblings of patients receiving unrelated marrow, PBSC, or cord blood transplantation. Important percentages of pediatric donors reported very poor psychosocial (20%) and overall (13%) HRQoL and parents overestimated their donor child's HRQoL. Donors had significantly better HRQoL than recipients and worse HRQoL than parent proxy reports. Multiple donor, recipient, parent and transplant center characteristics were associated with HRQoL in bivariate analyses. Multivariable analyses by donor age group suggested that donor HRQoL was significantly negatively associated with donor self-reported anxiety, depression and parental education and significantly positively associated with family cohesion, understanding of donation and proxy reports of donor HRQoL. The link between donor HRQoL and recipient and parent health and well-being suggests that variations in donor HRQoL do not occur in isolation but affect and/or are affected by the overall functioning and well-being of other family members and the family as a whole. Particularly striking is the association of donor HRQoL with perceived understanding of the donation process-improved donor education is a potential pathway to improving donor HRQoL. Assessment of-and Interventions to mitigate-risks to donors should involve the functioning of the family as a whole and not just the donor.

Indexed as

Hematopoietic Stem Cell TransplantationQuality of LifeSiblingsTissue DonorsAdolescentAdultChildChild, PreschoolFemaleHumansMaleProspective StudiesSurveys and QuestionnairesHematopoietic cellHRQoLPediatric donor

Identifiers

PMID41997298
PMCPMC13479314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.